mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-05 |
mRNA |
AICAR |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
9e-05 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
9e-05 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.23 |
0.0001 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0001 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0002 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.24 |
0.0002 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0002 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
0.0002 |
mRNA |
AT-7519 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.0002 |